Your browser doesn't support javascript.
loading
Cost-effectiveness Analysis of Four Different Drugs for Benign Prostatic Hypertrophy / 中国药房
China Pharmacy ; (12)2001.
Artículo en Chino | WPRIM | ID: wpr-517866
ABSTRACT

AIM:

To evaluate the economic effectiveness of different therapeutic schemes for benign prostatic hypertrophy

METHODS:

175 patients with benign prostatic hypertrophy were divided into 4 groupsA,B,C and D They received different drugs,Atamsulosin(34),Bprostat(45),Ctedenan(46) and Dqiangliexin(50)

RESULTS:

The costs of A,B,C,D schemes were RMB 492 80,499 52,526 40 and 664 16 yuans,respectively,and the effective ratios were 85 3%,82 2%,80 4% and 80 0%,respectively

CONCLUSION:

According to the evaluation with pharmacoeconomic cost-effectiveness analysis,A is the best scheme

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Evaluación Económica en Salud Idioma: Chino Revista: China Pharmacy Año: 2001 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Evaluación Económica en Salud Idioma: Chino Revista: China Pharmacy Año: 2001 Tipo del documento: Artículo